Depression and Anxiety Disorders in Patients With Inflammatory Bowel Disease

Overview

Journal Front Psychiatry

Specialty Psychiatry

Date 2021 Oct 25

PMID 34690829

Citations 24

Authors

Shurong Hu

Yiping Chen

Yan Chen

Caihua Wang

Affiliations

Soon will be listed here.

Abstract

Mental health is a significant yet overlooked aspect of inflammatory bowel disease (IBD) patient care, with challenges in determining optimal treatments and psychological health resources. The most common psychological conditions in patients with IBD are anxiety and depression. The increased prevalence of these mental disorders appeals to mental screening of each person diagnosed with IBD at initial consultation. There are simple and clinically viable methods available to screen for mental problems. Psychological methods may be as or even more significant as a therapeutic modality. Herein we discuss the three major areas of psychological co-morbidity in IBD: (1) the prevalence and risk factors associated with anxiety and depression disorders for patients with IBD; (2) diagnosis of psychological disorders for patients with IBD; (3) treatment with patients with IBD and mental disorders. The gastroenterologists are encouraged to screen and treat these patients with IBD and mental disorders, which may improve outcomes.

Citing Articles

Interprofessional approach to personalized medication management and therapy optimization in IBD care.

Fleischmann D, Binder B, Huss M, Elger T, Wolf C, Loibl J Front Med (Lausanne). 2025; 12:1446695.

PMID: 39944491 PMC: 11814462. DOI: 10.3389/fmed.2025.1446695.

Burden of Common Mental Disorders in Ulcerative Colitis and Irritable Bowel Syndrome Patients: An Analysis of Risk Factors.

Onisor D, Avram C, Ruta F, Brusnic O, Boeriu A, Stoian M J Clin Med. 2025; 14(2).

PMID: 39860505 PMC: 11766210. DOI: 10.3390/jcm14020499.

Roundtable on Young Adults with IBD: A multi-stakeholder perspective and patient-driven analysis of the current transitional challenges and gaps in research.

Dave S, Reed S, Patel K, Kim S Health Care Transit. 2024; 1:100006.

PMID: 39713018 PMC: 11658056. DOI: 10.1016/j.hctj.2023.100006.

Gut microbial and human genetic signatures of inflammatory bowel disease increase risk of comorbid mental disorders.

Lee J, Oh S, Ha E, Shin G, Kim H, Kim K NPJ Genom Med. 2024; 9(1):52.

PMID: 39472439 PMC: 11522461. DOI: 10.1038/s41525-024-00440-w.

Exploring the management and treatment of IBD from the perspective of psychological comorbidities.

Feng L, Cai X, Zou Q, Peng Y, Xu L, Wang L Therap Adv Gastroenterol. 2024; 17:17562848241290685.

PMID: 39421001 PMC: 11483836. DOI: 10.1177/17562848241290685.

References

Topp C, Ostergaard S, Sondergaard S, Bech P . The WHO-5 Well-Being Index: a systematic review of the literature. Psychother Psychosom. 2015; 84(3):167-76. DOI: 10.1159/000376585. View

Manea L, Gilbody S, McMillan D . Optimal cut-off score for diagnosing depression with the Patient Health Questionnaire (PHQ-9): a meta-analysis. CMAJ. 2011; 184(3):E191-6. PMC: 3281183. DOI: 10.1503/cmaj.110829. View

Wittchen H, Muhlig S, Beesdo K . Mental disorders in primary care. Dialogues Clin Neurosci. 2011; 5(2):115-28. PMC: 3181625. View

Weiller E, Bisserbe J, Maier W, Lecrubier Y . Prevalence and recognition of anxiety syndromes in five European primary care settings. A report from the WHO study on Psychological Problems in General Health Care. Br J Psychiatry Suppl. 1998; (34):18-23. View

Kroenke K, Spitzer R, Williams J . The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001; 16(9):606-13. PMC: 1495268. DOI: 10.1046/j.1525-1497.2001.016009606.x. View

Gracie D, Guthrie E, Hamlin P, Ford A . Bi-directionality of Brain-Gut Interactions in Patients With Inflammatory Bowel Disease. Gastroenterology. 2018; 154(6):1635-1646.e3. DOI: 10.1053/j.gastro.2018.01.027. View

Sareen J, Stein M, Campbell D, Hassard T, Menec V . The relation between perceived need for mental health treatment, DSM diagnosis, and quality of life: a Canadian population-based survey. Can J Psychiatry. 2005; 50(2):87-94. DOI: 10.1177/070674370505000203. View

Goodhand J, Greig F, Koodun Y, McDermott A, Wahed M, Langmead L . Do antidepressants influence the disease course in inflammatory bowel disease? A retrospective case-matched observational study. Inflamm Bowel Dis. 2012; 18(7):1232-9. DOI: 10.1002/ibd.21846. View

Spitzer R, Kroenke K, Williams J, Lowe B . A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006; 166(10):1092-7. DOI: 10.1001/archinte.166.10.1092. View

10.

Regueiro M, Greer J, Szigethy E . Etiology and Treatment of Pain and Psychosocial Issues in Patients With Inflammatory Bowel Diseases. Gastroenterology. 2016; 152(2):430-439.e4. DOI: 10.1053/j.gastro.2016.10.036. View

11.

Neuendorf R, Harding A, Stello N, Hanes D, Wahbeh H . Depression and anxiety in patients with Inflammatory Bowel Disease: A systematic review. J Psychosom Res. 2016; 87:70-80. DOI: 10.1016/j.jpsychores.2016.06.001. View

12.

Zimmerman M, Martinez J, Young D, Chelminski I, Dalrymple K . Severity classification on the Hamilton Depression Rating Scale. J Affect Disord. 2013; 150(2):384-8. DOI: 10.1016/j.jad.2013.04.028. View

13.

Lader M, Farr I, Morton S . A comparison of alpidem and placebo in relieving benzodiazepine withdrawal symptoms. Int Clin Psychopharmacol. 1993; 8(1):31-6. DOI: 10.1097/00004850-199300810-00005. View

14.

Tarescavage A, Forner E, Ben-Porath Y . Construct Validity of Level 2 Assessments (PROMIS Depression, Anxiety, and Anger): Evidence From the MMPI-2-RF. Assessment. 2020; 28(3):788-795. DOI: 10.1177/1073191120911092. View

15.

Fujitsuka N, Asakawa A, Hayashi M, Sameshima M, Amitani H, Kojima S . Selective serotonin reuptake inhibitors modify physiological gastrointestinal motor activities via 5-HT2c receptor and acyl ghrelin. Biol Psychiatry. 2008; 65(9):748-59. DOI: 10.1016/j.biopsych.2008.10.031. View

16.

Rozich J, Holmer A, Singh S . Effect of Lifestyle Factors on Outcomes in Patients With Inflammatory Bowel Diseases. Am J Gastroenterol. 2020; 115(6):832-840. PMC: 7274876. DOI: 10.14309/ajg.0000000000000608. View

17.

Ishak W, Pan D, Steiner A, Feldman E, Mann A, Mirocha J . Patient-Reported Outcomes of Quality of Life, Functioning, and GI/Psychiatric Symptom Severity in Patients with Inflammatory Bowel Disease (IBD). Inflamm Bowel Dis. 2017; 23(5):798-803. DOI: 10.1097/MIB.0000000000001060. View

18.

Mawdsley J, Jenkins D, Macey M, Langmead L, Rampton D . The effect of hypnosis on systemic and rectal mucosal measures of inflammation in ulcerative colitis. Am J Gastroenterol. 2008; 103(6):1460-9. DOI: 10.1111/j.1572-0241.2008.01845.x. View

19.

Mikocka-Walus A, Bampton P, Hetzel D, Hughes P, Esterman A, Andrews J . Cognitive-behavioural therapy has no effect on disease activity but improves quality of life in subgroups of patients with inflammatory bowel disease: a pilot randomised controlled trial. BMC Gastroenterol. 2015; 15:54. PMC: 4427935. DOI: 10.1186/s12876-015-0278-2. View

20.

Yanartas O, Kani H, Bicakci E, Kilic I, Banzragch M, Acikel C . The effects of psychiatric treatment on depression, anxiety, quality of life, and sexual dysfunction in patients with inflammatory bowel disease. Neuropsychiatr Dis Treat. 2016; 12:673-83. PMC: 4818049. DOI: 10.2147/NDT.S106039. View